99 related articles for article (PubMed ID: 12138327)
1. Actions of farnesol and xylitol against Staphylococcus aureus.
Akiyama H; Oono T; Huh WK; Yamasaki O; Ogawa S; Katsuyama M; Ichikawa H; Iwatsuki K
Chemotherapy; 2002 Jul; 48(3):122-8. PubMed ID: 12138327
[TBL] [Abstract][Full Text] [Related]
2. A novel method to control the balance of skin microflora. Part 1. Attack on biofilm of Staphylococcus aureus without antibiotics.
Katsuyama M; Ichikawa H; Ogawa S; Ikezawa Z
J Dermatol Sci; 2005 Jun; 38(3):197-205. PubMed ID: 15927813
[TBL] [Abstract][Full Text] [Related]
3. A novel method to control the balance of skin microflora Part 2. A study to assess the effect of a cream containing farnesol and xylitol on atopic dry skin.
Katsuyama M; Kobayashi Y; Ichikawa H; Mizuno A; Miyachi Y; Matsunaga K; Kawashima M
J Dermatol Sci; 2005 Jun; 38(3):207-13. PubMed ID: 15927814
[TBL] [Abstract][Full Text] [Related]
4. Effect of farnesol on Staphylococcus aureus biofilm formation and antimicrobial susceptibility.
Jabra-Rizk MA; Meiller TF; James CE; Shirtliff ME
Antimicrob Agents Chemother; 2006 Apr; 50(4):1463-9. PubMed ID: 16569866
[TBL] [Abstract][Full Text] [Related]
5. Actions of gluco-oligosaccharide against Staphylococcus aureus.
Akiyama H; Oono T; Huh WK; Yamasaki O; Akagi Y; Uemura H; Yamada T; Iwatsuki K
J Dermatol; 2002 Sep; 29(9):580-6. PubMed ID: 12392066
[TBL] [Abstract][Full Text] [Related]
6. Sesquiterpene farnesol inhibits recycling of the C55 lipid carrier of the murein monomer precursor contributing to increased susceptibility to beta-lactams in methicillin-resistant Staphylococcus aureus.
Kuroda M; Nagasaki S; Ohta T
J Antimicrob Chemother; 2007 Mar; 59(3):425-32. PubMed ID: 17242033
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility testing and resistance phenotype detection in Staphylococcus aureus strains isolated from patients with atopic dermatitis, with apparent and recurrent skin colonization.
Kedzierska A; Kapińska-Mrowiecka M; Czubak-Macugowska M; Wójcik K; Kedzierska J
Br J Dermatol; 2008 Dec; 159(6):1290-9. PubMed ID: 18795934
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial action of several tannins against Staphylococcus aureus.
Akiyama H; Fujii K; Yamasaki O; Oono T; Iwatsuki K
J Antimicrob Chemother; 2001 Oct; 48(4):487-91. PubMed ID: 11581226
[TBL] [Abstract][Full Text] [Related]
9. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
[TBL] [Abstract][Full Text] [Related]
10. Sesquiterpene farnesol as a competitive inhibitor of lipase activity of Staphylococcus aureus.
Kuroda M; Nagasaki S; Ito R; Ohta T
FEMS Microbiol Lett; 2007 Aug; 273(1):28-34. PubMed ID: 17559400
[TBL] [Abstract][Full Text] [Related]
11. Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureus.
Rand KH; Houck HJ
Antimicrob Agents Chemother; 2004 Aug; 48(8):2871-5. PubMed ID: 15273094
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial effects of acidic hot-spring water on Staphylococcus aureus strains isolated from atopic dermatitis patients.
Akiyama H; Yamasaki O; Tada J; Kubota K; Arata J
J Dermatol Sci; 2000 Nov; 24(2):112-8. PubMed ID: 11064246
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target.
Andes D; Craig WA
Antimicrob Agents Chemother; 2006 Apr; 50(4):1376-83. PubMed ID: 16569855
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility of Staphylococcus aureus in children with atopic dermatitis.
Tang CS; Wang CC; Huang CF; Chen SJ; Tseng MH; Lo WT
Pediatr Int; 2011 Jun; 53(3):363-7. PubMed ID: 20723106
[TBL] [Abstract][Full Text] [Related]
15. [Methicillin resistance and vancomycin susceptibility pattern among blood isolates of Staphylococcus aureus].
Rodríguez-Pineda J; Terrazas-Estrada JJ; Urdez-Hernández E; Hernández-Sánchez EA; Sánchez-Tejeda SL
Rev Med Inst Mex Seguro Soc; 2016; 54(1):48-51. PubMed ID: 26820198
[TBL] [Abstract][Full Text] [Related]
16. [Treatment with arbekacin of surgical infections by resistant strains of Staphylococcus aureus. Arbekacin Study Group].
Morimoto K; Nakatani S; Kaji M; Kinoshita H; Fujimoto M; Hirata S; Ueda T; Tamate S; Yamazaki O
Jpn J Antibiot; 1994 Jun; 47(6):826-36. PubMed ID: 8072193
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).
Farrell DJ; Castanheira M; Mendes RE; Sader HS; Jones RN
Clin Infect Dis; 2012 Sep; 55 Suppl 3():S206-14. PubMed ID: 22903953
[TBL] [Abstract][Full Text] [Related]
18. Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis.
Cervera C; Castañeda X; de la Maria CG; del Rio A; Moreno A; Soy D; Pericas JM; Falces C; Armero Y; Almela M; Ninot S; Pare JC; Mestres CA; Gatell JM; Marco F; Miro JM;
Clin Infect Dis; 2014 Jun; 58(12):1668-75. PubMed ID: 24647021
[TBL] [Abstract][Full Text] [Related]
19. Skin colonization by superantigen-producing Staphylococcus aureus in Egyptian patients with atopic dermatitis and its relation to disease severity and serum interleukin-4 level.
Nada HA; Gomaa NI; Elakhras A; Wasfy R; Baker RA
Int J Infect Dis; 2012 Jan; 16(1):e29-33. PubMed ID: 22040925
[TBL] [Abstract][Full Text] [Related]
20. Deficient production of hexadecenoic acid in the skin is associated in part with the vulnerability of atopic dermatitis patients to colonization by Staphylococcus aureus.
Takigawa H; Nakagawa H; Kuzukawa M; Mori H; Imokawa G
Dermatology; 2005; 211(3):240-8. PubMed ID: 16205069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
